TransMedics ( TMDX )

Growth

Flagship platform with active clinical trials; core revenue driver for the company's transplant preservation strategy.

OCS Lung System

Share Interview Share Compensation

Help build intelligence for TransMedics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

High-growth trajectory with revenue surging 160% from FY2024 ($93M) to FY2025 ($242M), signaling strong market traction
Focused portfolio across critical organs (heart, lung, liver) addresses unmet needs in transplantation with regulatory pathway clarity
Public company status provides equity upside potential and access to capital markets for expansion

Watch Out For

Still unprofitable ($25M net loss in FY2025) despite revenue growth, indicating margin pressure or continued heavy investment burn
Narrow therapeutic focus on transplant preservation limits internal mobility and diversification opportunities within the company

Generated by Claude from TransMedics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Multi-indication platform addressing lung preservation and bronchiolitis obliterans prevention in transplant patients.

OCS Liver System

Growth

Completes the organ preservation portfolio; addresses high-value liver transplant market segment.

Pipeline & Clinical Trials

OCS™ Liver System

Liver Transplantation

N/A

Clinical Trials (1)

NCT02522871OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation

N/A

Organ Care System

Heart Failure

N/A

OCS Heart System

Transplant

N/A

Clinical Trials (1)

NCT05047068OCS Heart Perfusion Post-Approval Registry

N/A

OCS Lung System

N/A

Clinical Trials (1)

NCT04194398OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection

N/A

OCS Lung Preservation

N/A

Clinical Trials (1)

NCT01963780International EXPAND Lung Pivotal Trial

N/A

OCS Liver

N/A

Clinical Trials (1)

NCT05096741OCS Liver PROTECT Continuation Post-Approval Study

N/A

OCS Heart System

N/A

Clinical Trials (1)

NCT03835754Heart EXPAND Continued Access Protocol

N/A

OCS Heart

N/A

Clinical Trials (1)

NCT05741723OCS DCD Heart + CAP Continued Follow-Up

N/A

OCS Lung

N/A

Clinical Trials (1)

NCT06513091US National TOP Registry

N/A

OCS Heart

N/A

Clinical Trials (1)

NCT05096299OCS Heart EXPAND + CAP Continued Follow-Up

N/A

Transplant

N/A

Clinical Trials (1)

NCT04615182Donor After Circulatory Death Heart CAP Trial

N/A

OCS Liver System

N/A

Clinical Trials (1)

NCT04194437OCS Liver DCD Trial

N/A

Preservation of Hearts for Transplantation

N/A

Clinical Trials (1)

NCT02323321International EXPAND Heart Pivotal Trial

N/A

OCS Heart System

N/A

Clinical Trials (1)

NCT03831048Donors After Circulatory Death Heart Trial

N/A

OCS Heart

N/A

Clinical Trials (1)

NCT05915299US National OCS Heart Perfusion (OHP) Registry

N/A

OCS Lung System

Bronchiolitis Obliterans

N/A

Clinical Trials (1)

NCT03868904INSPIRE Continuation Post-Approval Study

N/A

OCS Lung

Lung Preservation

N/A

Clinical Trials (1)

NCT01630434International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation

N/A

OCS Liver

N/A

Clinical Trials (1)

NCT05074160OCS Liver Perfusion (OLP) Post-Approval Registry

N/A

OCS Lung Preservation

Lung Transplantation

N/A

Clinical Trials (1)

NCT03343535OCS Lung System EXPAND II Trial

N/A

OCS Liver

N/A

Clinical Trials (1)

NCT05096754OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

N/A

OCS Lung System

N/A

Clinical Trials (1)

NCT07340710Decreasing Edema With a Novel OCS Solution Trial

N/A

OCS Heart

N/A

Clinical Trials (1)

NCT07145515Enhancing Heart Allograft Function With the OCS Heart System Trial

N/A

OCS Liver

N/A

Clinical Trials (1)

NCT05940857US National OCS Liver Perfusion (OLP) Registry

N/A

OCS Lung System

Lung Transplantation

N/A

Clinical Trials (1)

NCT03639025OCS™ Lung TOP Registry For Donor Lungs for Transplantation

N/A

OCS Liver System